Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1

Nature Genetics

Volumn 45, Issue 2, 2013, Pages 202-207

  Kirino, Yohei ^a,b   Bertsias, George ^a,c   Ishigatsubo, Yoshiaki ^b   Mizuki, Nobuhisa ^b   Tugal Tutkun, Ilknur ^d   Seyahi, Emire ^e   Ozyazgan, Yilmaz ^d   Sacli, F Sevgi ^e   Erer, Burak ^d   Inoko, Hidetoshi ^f   Emrence, Zeliha ^e   Cakar, Atilla ^e   Abaci, Neslihan ^e   Ustek, Duran ^e   Satorius, Colleen ^a   Ueda, Atsuhisa ^b   Takeno, Mitsuhiro ^b   Kim, Yoonhee ^a   Wood, Geryl M ^a   Ombrello, Michael J ^a   Meguro, Akira ^b   Gül, Ahmet ^d   Remmers, Elaine F ^a   Kastner, Daniel L ^a   more..

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CRETE   (Greece)

^d ISTANBUL UNIVERSITY   (Turkey)

^e ISTANBUL UNIVERSITY   (Turkey)

^f TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR1; ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; HLA B51 ANTIGEN; INTERLEUKIN 23 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN; STAT4 PROTEIN; UNCLASSIFIED DRUG;

ANKYLOSING SPONDYLITIS; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; ENTERITIS; EPISTASIS; GENE EXPRESSION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSORIASIS; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINOPEPTIDASES; ANALYSIS OF VARIANCE; BEHCET SYNDROME; EPISTASIS, GENETIC; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HLA-B51 ANTIGEN; HUMANS; JAPAN; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR1; STAT4 TRANSCRIPTION FACTOR; STATISTICS, NONPARAMETRIC; TURKEY;

EID: 84873091770     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2520     Document Type: Article

References (37)

1. Sakane, T., Takeno, M., Suzuki, N. & Inaba, G. Behçet's disease. N. Engl. J. Med. 341, 1284-1291 (1999).
2. Yazici, H., Fresko, I. & Yurdakul, S. Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat. Clin. Pract. Rheumatol. 3, 148-155 (2007).
3. Ono, S., Aoki, K., Sugiura, S., Nakayama, E. & Itakura, K. Letter: HL-A5 and Behçet's disease. Lancet 2, 1383-1384 (1973).
4. de Menthon, M., Lavalley, M.P., Maldini, C., Guillevin, L. & Mahr, A. HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 61, 1287-1296 (2009).
5. Gül, A. & Ohno, S. HLA-B&z.ast;51 and Behçet disease. Ocul. Immunol. Inflamm. 20, 37-43 (2012).
6. Remmers, E.F. et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat. Genet. 42, 698-702 (2010).
7. Mizuki, N. et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat. Genet. 42, 703-706 (2010).
8. Moll, J.M., Haslock, I., Macrae, I.F. & Wright, V. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behçet's syndrome. Medicine (Baltimore) 53, 343-364 (1974).
9. Chang, H.K. et al. The comparison between Behçet's disease and spondyloarthritides: does Behçet's disease belong to the spondyloarthropathy complex? J. Korean Med. Sci. 17, 524-529 (2002).
10. Yazici, H., Tuzlaci, M. & Yurdakul, S. A controlled survey of sacroiliitis in Behçet's disease. Ann. Rheum. Dis. 40, 558-559 (1981).
11. Olivieri, I., Salvarani, C. & Cantini, F. Is Behçet's disease part of the spondyloarthritis complex? J. Rheumatol. 24, 1870-1872 (1997).
12. Burton, P.R. et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 39, 1329-1337 (2007).
13. Duerr, R.H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463 (2006).
14. Nair, R.P. et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways. Nat. Genet. 41, 199-204 (2009).
15. Ohno, S. et al. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis. J. Rheumatol. 31, 1362-1368 (2004).
16. Dougados, M. & Baeten, D. Spondyloarthritis. Lancet 377, 2127-2137 (2011).
17. Franke, A. et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42, 1118-1125 (2010).
18. Anderson, C.A. et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 43, 246-252 (2011).
19. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 335, 1078-1080 (1990).
20. Haroon, N. & Inman, R.D. Endoplasmic reticulum aminopeptidases: biology and pathogenic potential. Nat. Rev. Rheumatol. 6, 461-467 (2010).
21. Sun, L.D. et al. Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat. Genet. 42, 1005-1009 (2010).
22. Strange, A. et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat. Genet. 42, 985-990 (2010).
23. Evans, D.M. et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat. Genet. 43, 761-767 (2011).
24. Kochan, G. et al. Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc. Natl. Acad. Sci. USA 108, 7745-7750 (2011).
25. York, I.A., Brehm, M.A., Zendzian, S., Towne, C.F. & Rock, K.L. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proc. Natl. Acad. Sci. USA 103, 9202-9207 (2006).
26. Gebreselassie, D., Spiegel, H. & Vukmanovic, S. Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B&z.ast;5101 with peptides. Hum. Immunol. 67, 894-906 (2006).
27. Hayashi, T. et al. Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance. Cancer Res. 66, 563-570 (2006).
28. Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-729 (1999).
29. Raulet, D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3, 781-790 (2003).
30. Karasneh, J., Gül, A., Ollier, W.E., Silman, A.J. & Worthington, J. Whole-genome screening for susceptibility genes in multicase families with Behçet's disease. Arthritis Rheum. 52, 1836-1842 (2005).
31. Zeller, T. et al. Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PLoS ONE 5, e10693 (2010).
32. Remmers, E.F. et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med. 357, 977-986 (2007).
33. Abelson, A.K. et al. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann. Rheum. Dis. 68, 1746-1753 (2009).
34. Zollner, S. & Pritchard, J.K. Overcoming the winner's curse: estimating penetrance parameters from case-control data. Am. J. Hum. Genet. 80, 605-615 (2007).
35. Livneh, A. et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 40, 1879-1885 (1997).
36. Stranger, B.E. et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315, 848-853 (2007).
37. Niu, N. et al. Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines. Genome Res. 20, 1482-1492 (2010).